Literature DB >> 22004696

Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver.

Bruno Douradinha1, Melissa van Dijk, Geert-Jan van Gemert, Shahid M Khan, Chris J Janse, Andy P Waters, Robert W Sauerwein, Adrian Jf Luty, Bruno Silva-Santos, Maria M Mota, Sabrina Epiphanio.   

Abstract

BACKGROUND: The induction of sterile immunity and long lasting protection against malaria has been effectively achieved by immunization with sporozoites attenuated by gamma-irradiation or through deletion of genes. For mice immunized with radiation attenuated sporozoites (RAS) it has been shown that intrahepatic effector memory CD8+ T cells are critical for protection. Recent studies have shown that immunization with genetically attenuated parasites (GAP) in mice is also conferred by liver effector memory CD8+ T cells.
FINDINGS: In this study we analysed effector memory cell responses after immunization of GAP that lack the P52 protein. We demonstrate that immunization with p52-GAP sporozoites also results in a strong increase of effector memory CD8+ T cells, even 6 months after immunization, whereas no specific CD4+ effector T cells response could be detected. In addition, we show that the increase of effector memory CD8+ T cells is specific for the liver and not for the spleen or lymph nodes.
CONCLUSIONS: These results indicate that immunization of mice with P. berghei p52-GAP results in immune responses that are comparable to those induced by RAS or GAP lacking expression of UIS3 or UIS4, with an important role implicated for intrahepatic effector memory CD8+ T cells. The knowledge of the mediators of protective immunity after immunization with different GAP is important for the further development of vaccines consisting of genetically attenuated sporozoites.

Entities:  

Year:  2011        PMID: 22004696      PMCID: PMC3206817          DOI: 10.1186/1476-8518-9-6

Source DB:  PubMed          Journal:  J Immune Based Ther Vaccines        ISSN: 1476-8518


  20 in total

1.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.

Authors:  Ann-Kristin Mueller; Mehdi Labaied; Stefan H I Kappe; Kai Matuschewski
Journal:  Nature       Date:  2004-12-05       Impact factor: 49.962

Review 2.  The dissection of CD8 T cells during liver-stage infection.

Authors:  U Krzych; J Schwenk
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

3.  Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte.

Authors:  Tomoko Ishino; Yasuo Chinzei; Masao Yuda
Journal:  Mol Microbiol       Date:  2005-12       Impact factor: 3.501

4.  Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites.

Authors:  M Guebre-Xabier; R Schwenk; U Krzych
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

5.  Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

Authors:  Ann-Kristin Mueller; Nelly Camargo; Karine Kaiser; Cathy Andorfer; Ute Frevert; Kai Matuschewski; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

6.  Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.

Authors:  Melissa R van Dijk; Bruno Douradinha; Blandine Franke-Fayard; Volker Heussler; Maaike W van Dooren; Ben van Schaijk; Geert-Jan van Gemert; Robert W Sauerwein; Maria M Mota; Andrew P Waters; Chris J Janse
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.

Authors:  Ian A Cockburn; Yun-Chi Chen; Michael G Overstreet; Jason R Lees; Nico van Rooijen; Donna L Farber; Fidel Zavala
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

Review 8.  Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.

Authors:  Stephen L Hoffman; Peter F Billingsley; Eric James; Adam Richman; Mark Loyevsky; Tao Li; Sumana Chakravarty; Anusha Gunasekera; Rana Chattopadhyay; Minglin Li; Richard Stafford; Adriana Ahumada; Judith E Epstein; Martha Sedegah; Sharina Reyes; Thomas L Richie; Kirsten E Lyke; Robert Edelman; Matthew B Laurens; Christopher V Plowe; B Kim Lee Sim
Journal:  Hum Vaccin       Date:  2010-01-21

9.  Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites.

Authors:  L F Scheller; A F Azad
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.

Authors:  Dmitri Berenzon; Robert J Schwenk; Lisa Letellier; Mimi Guebre-Xabier; Jackie Williams; Urszula Krzych
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  4 in total

1.  A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion.

Authors:  Sebastian A Mikolajczak; Viswanathan Lakshmanan; Matthew Fishbaugher; Nelly Camargo; Anke Harupa; Alexis Kaushansky; Alyse N Douglass; Michael Baldwin; Julie Healer; Matthew O'Neill; Thuan Phuong; Alan Cowman; Stefan H I Kappe
Journal:  Mol Ther       Date:  2014-05-14       Impact factor: 11.454

2.  CSP--a model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes.

Authors:  Saidou Balam; Jackeline F Romero; Silayuv E Bongfen; Philippe Guillaume; Giampietro Corradin
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

3.  Synthetic DNA Vaccines Adjuvanted with pIL-33 Drive Liver-Localized T Cells and Provide Protection from Plasmodium Challenge in a Mouse Model.

Authors:  Sophia M Reeder; Emma L Reuschel; Mamadou A Bah; Kun Yun; Nicholas J Tursi; Kevin Y Kim; Jacqueline Chu; Faraz I Zaidi; Ilknur Yilmaz; Robert J Hart; Benjamin Perrin; Ziyang Xu; Laurent Humeau; David B Weiner; Ahmed S I Aly
Journal:  Vaccines (Basel)       Date:  2020-01-10

Review 4.  Malaria Vaccine Development: The Need for Novel Approaches: A Review Article.

Authors:  Shima Mahmoudi; Hossein Keshavarz
Journal:  Iran J Parasitol       Date:  2018 Jan-Mar       Impact factor: 1.012

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.